UCX Trademark

Trademark Overview

On Friday, September 21, 2012, a trademark application was filed for UCX with the United States Patent and Trademark Office. The USPTO has given the UCX trademark a serial number of 79120454. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 21, 2022. This trademark is owned by ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.. The UCX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration; Biological preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration
ucx

General Information

Serial Number79120454
Word MarkUCX
Filing DateFriday, September 21, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 21, 2022
Registration Number4427095
Registration DateTuesday, November 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration; Biological preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameECBIO, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressP-2700-451 AMADORA
PT
Party NameECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressP-2700-451 AMADORA
PT
Party NameECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressP-2700-451 AMADORA
PT

Trademark Events

Event DateEvent Description
Monday, April 17, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, April 17, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, January 9, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, November 17, 2021GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, November 17, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, October 11, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 15, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 5, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, April 2, 2014CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, March 20, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Friday, February 28, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 7, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 7, 2014FINAL DISPOSITION PROCESSED
Wednesday, February 5, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 5, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2013ASSIGNED TO LIE
Sunday, June 2, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 14, 2013REFUSAL PROCESSED BY IB
Tuesday, January 22, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 22, 2013REFUSAL PROCESSED BY MPU
Tuesday, January 22, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 21, 2013NON-FINAL ACTION WRITTEN
Monday, January 21, 2013ASSIGNED TO EXAMINER
Tuesday, December 4, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, November 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 22, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

diseases peripheral disease related crohn arthritis degenerative regeneration nerve central